Zespół pradera-williego
Leczenie

Zespół Pradera-Williego (PWS) to złożone, genetyczne zaburzenie neurorozwojowe, charakteryzujące się m.in. obniżonym napięciem mięśniowym, hiperfagią oraz zaburzeniami endokrynologicznymi. Kluczowym elementem terapii jest wczesne, wielodyscyplinarne podejście obejmujące pediatrę, endokrynologa, genetyka, dietetyka, fizjoterapeutę, psychologa i innych specjalistów. Terapia rekombinowanym ludzkim hormonem wzrostu (rhGH) stosowana jest od niemowlęctwa (zalecana dawka 0,7 IU/kg/tydzień, tj. 0,23 mg/kg/tydzień) i przynosi korzyści takie jak zwiększenie wzrostu, poprawa składu ciała, siły mięśniowej, gęstości kości oraz rozwoju motorycznego i poznawczego. Przed terapią konieczne jest wykonanie polisomnografii, ocena dróg oddechowych i funkcji tarczycy. U dorosłych rhGH stosuje się po potwierdzeniu niedoboru hormonu wzrostu, choć dane są ograniczone. Leczenie hipogonadyzmu, niedoczynności tarczycy i centralnej niewydolności nadnerczy jest integralną częścią opieki endokrynologicznej.

Wprowadzenie do zespołu Pradera-Williego

Zespół Pradera-Williego (PWS) to złożone, genetyczne zaburzenie neurorozwojowe, będące najczęstszą genetyczną przyczyną otyłości u dzieci. Charakteryzuje się obniżonym napięciem mięśniowym, trudnościami w uczeniu się, hiperfagią (niekontrolowanym głodem) oraz licznymi zaburzeniami endokrynologicznymi. PWS wymaga kompleksowego, wielodyscyplinarnego podejścia terapeutycznego, które powinno rozpocząć się możliwie wcześnie po rozpoznaniu, aby poprawić ogólną jakość życia pacjentów, zapobiec powikłaniom i wydłużyć przewidywaną długość życia.123

Obecnie nie istnieje lekarstwo, które mogłoby całkowicie wyleczyć zespół Pradera-Williego, jednak dostępne są różnorodne metody terapeutyczne ukierunkowane na łagodzenie objawów i poprawę funkcjonowania pacjentów. Wczesna diagnoza i wielokierunkowe leczenie mogą znacząco poprawić rokowanie.456

Wielodyscyplinarne podejście do leczenia

Leczenie zespołu Pradera-Williego wymaga zaangażowania zespołu różnych specjalistów ze względu na złożoność objawów i mnogość układów objętych chorobą. W skład zespołu terapeutycznego powinni wchodzić między innymi: pediatra, endokrynolog, genetyk, dietetyk, fizjoterapeuta, terapeuta zajęciowy, logopeda, psycholog, psychiatra, ortopeda, neurolog i inni specjaliści w zależności od indywidualnych potrzeb pacjenta.456

Badania wykazały, że holistyczna opieka i zintegrowane usługi zapewniają lepsze wyniki dla osób z zespołem Pradera-Williego. Kompleksowe, wielodyscyplinarne leczenie rozpoczynające się od okresu noworodkowego zmniejsza liczbę hospitalizacji i zapobiega wczesnej otyłości.78

Leczenie hormonem wzrostu

Terapia rekombinowanym ludzkim hormonem wzrostu (rhGH) jest kluczowym elementem leczenia zespołu Pradera-Williego, szczególnie u dzieci. Amerykańska Agencja ds. Żywności i Leków (FDA) zatwierdziła stosowanie hormonu wzrostu u dzieci z genetycznie potwierdzonym PWS i dowodami na zaburzenia wzrostu 20 czerwca 2000 roku.910

Korzyści z terapii hormonem wzrostu

Leczenie hormonem wzrostu przynosi szereg korzyści u pacjentów z zespołem Pradera-Williego:1112

131415

Metaanaliza pięciu randomizowanych badań obejmujących 154 niemowlęta i dzieci z PWS (w wieku od 1,3 do 3 lat) wykazała, że osoby otrzymujące leczenie rekombinowanym ludzkim hormonem wzrostu osiągały wyższe wyniki w standaryzowanych testach rozwoju motorycznego. Terapia rhGH wykazała również poprawę rozwoju poznawczego w pierwszym roku leczenia.16

Wskazania i dawkowanie hormonu wzrostu

Leczenie hormonem wzrostu zaleca się rozpocząć wcześnie, najlepiej przed wystąpieniem otyłości, która często zaczyna się około drugiego roku życia. Niektórzy eksperci zalecają rozpoczęcie terapii już w wieku od 6 miesięcy do 2 lat, a nawet wcześniej (pomiędzy 3 a 6 miesiącem życia). Przed rozpoczęciem terapii hormonem wzrostu, pacjenci powinni mieć potwierdzone rozpoznanie molekularne PWS i przejść wielospecjalistyczną ocenę.171819

Zalecana dawka odpowiada tej stosowanej w leczeniu niedoboru hormonu wzrostu: 0,7 IU/kg/tydzień (0,23 mg/kg/tydzień). Badanie przeprowadzone przez Scheermeyer i wsp. wykazało, że u niemowląt (w wieku 2-12 miesięcy) z zespołem Pradera-Williego, efekty leczenia niską dawką hormonu wzrostu (4,5 mg/m²/tydzień) na wzrost i rozwój są porównywalne z efektami leczenia wyższą dawką (7 mg/m²/tydzień).2021

Warto zaznaczyć, że w Europie dzieci z PWS mogą być leczone hormonem wzrostu nawet jeśli nie mają niedoboru hormonu wzrostu lub opóźnienia wzrostu.21

Monitorowanie bezpieczeństwa terapii hormonem wzrostu

Przed rozpoczęciem terapii hormonem wzrostu konieczne jest przeprowadzenie badań oceniających bezpieczeństwo leczenia, w tym:2223

  • Badania snu (polisomnografia) – ze względu na ryzyko bezdechów sennych
  • Ocena górnych dróg oddechowych
  • Badania funkcji tarczycy
  • Monitorowanie krzywizny kręgosłupa

Grupa konsensusowa złożona z klinicystów z Wielkiej Brytanii i Republiki Irlandii z dużym doświadczeniem w zespole Pradera-Williego opracowała zalecenia dotyczące postępowania u dzieci do 18 roku życia. Według tej grupy, po uzyskaniu badania snu, hormon wzrostu powinien być zalecany do rozpoczęcia przed ukończeniem 1 roku życia. Ponadto zaleca się, aby u pacjentów poniżej 5 roku życia poddawanych terapii hormonem wzrostu przeprowadzać badanie snu poziomu 2 co najmniej co 2-3 lata, a badania te przeprowadzać wcześniej, jeśli istnieje kliniczne podejrzenie pogorszenia obturacyjnego bezdechu sennego.232425

Terapia hormonem wzrostu jest przeciwwskazana u pacjentów z:26

  • Ciężką otyłością
  • Niekontrolowaną cukrzycą
  • Istniejącą poważną skoliozą
  • Bezdechami sennymi

Terapia hormonem wzrostu u dorosłych z PWS

Według grupy konsensusowej, u dorosłych z zespołem Pradera-Williego terapia hormonem wzrostu może być stosowana do 25 roku życia, ale po tym czasie dane wspierające tę interwencję są skąpe. Terapia hormonem wzrostu u dorosłych powinna być rozpoczynana tylko po potwierdzeniu niedoboru hormonu wzrostu.232527

Niemniej jednak, terapia rhGH u dorosłych pacjentów z PWS może przynieść potencjalne korzyści, takie jak poprawa składu ciała, siły mięśniowej, zdrowia metabolicznego, funkcji poznawczych i jakości życia.2628

Leczenie zaburzeń hormonalnych innych niż hormon wzrostu

Terapia hormonami płciowymi

U pacjentów z zespołem Pradera-Williego często występuje hipogonadyzm, który wymaga leczenia hormonalnego. Endokrynolog może zasugerować, aby dziecko przyjmowało terapię zastępczą hormonami płciowymi: testosteronem dla chłopców lub estrogenem i progesteronem dla dziewcząt, z powodu niskiego poziomu hormonów płciowych.2930

Terapia hormonalna zwykle rozpoczyna się, gdy dziecko osiąga normalny wiek dojrzewania. Może ona zmniejszyć ryzyko osteoporozy (rozrzedzenia kości) i wspomóc rozwój drugorzędowych cech płciowych. U chłopców może być również wskazane leczenie ludzką gonadotropiną kosmówkową (hCG).293130

Wczesne leczenie hipogonadyzmu (w ciągu pierwszych 6 miesięcy życia) może być korzystne dla wielu chłopców z PWS. Dziecko może wymagać operacji korekcji wnętrostwa.2932

Leczenie innych zaburzeń endokrynologicznych

U pacjentów z PWS może również wystąpić niedoczynność tarczycy oraz centralna niewydolność nadnerczy, które wymagają odpowiedniej terapii hormonalnej. Zaleca się rozpoczęcie rutynowych badań tarczycy w pierwszym roku życia.3334

Kontrola masy ciała i leczenie hiperfagii

Jednym z głównych problemów w zespole Pradera-Williego jest hiperfagia (niekontrolowany głód) prowadząca do otyłości. Zarządzanie wagą jest kluczowym aspektem opieki nad osobami z PWS.3536

Dieta i zarządzanie odżywianiem

Pacjenci z zespołem Pradera-Williego mają obniżone zapotrzebowanie energetyczne, wynoszące około 70% kalorii w porównaniu do rówieśników bez PWS. Dietetyk może pomóc w stworzeniu zdrowej, niskokalorycznej diety, aby pomóc w zarządzaniu wagą dziecka, jednocześnie zapewniając odpowiednie odżywienie.3537

Wprowadzenie zbilansowanej diety hipokalorycznej (około 1000 kalorii z suplementacją witamin i wapnia) zaleca się generalnie we wczesnym wieku szkolnym pod ścisłym nadzorem dietetyka. Dieta wymaga często suplementacji witaminami lub minerałami, aby zapewnić zbilansowane odżywianie. Należy zachować ostrożność przy stosowaniu witamin w postaci gumowej ze względu na ich wysoką zawartość kalorii i ryzyko przedawkowania, biorąc pod uwagę ich smak przypominający słodycze.3837

U niemowląt z PWS, które mają trudności z karmieniem, mogą być zalecane specjalne smoczki lub sondy do karmienia oraz wysokoenergetyczne formuły lub specjalne techniki karmienia, aby pomóc dziecku przybrać na wadze.3940

Farmakoterapia hiperfagii

Przez wiele lat nie istniały skuteczne leki hamujące apetyt u pacjentów z PWS. Jednak 26 marca 2024 roku FDA zatwierdziła pierwszy lek do leczenia hiperfagii u pacjentów z zespołem Pradera-Williego w wieku powyżej 4 lat – VYKAT XR (diazoksyd choliny). Jest to pierwszy lek zatwierdzony do leczenia hiperfagii w PWS.414243

Diazoksyd choliny to lek doustny przyjmowany raz dziennie, który aktywuje kanał potasowy zależny od adenozynotrifosforanu i przenika barierę krew-mózg. Zatwierdzenie nastąpiło po pozytywnych wynikach badania klinicznego fazy 3 (ZEPHYR), które wykazało statystycznie istotne pogorszenie hiperfagii u osób, które przestawiono na placebo w porównaniu z tymi, które pozostały na diazoksydzie choliny.44

Profil bezpieczeństwa leku jest korzystny, a najczęstszymi działaniami niepożądanymi są hipertrichoza (nadmierne owłosienie), obrzęk, hiperglikemia i wysypka, które występowały u ≥10% uczestników.44

Inne leki badane w leczeniu hiperfagii w PWS to:4546

  • Eksenatyd i liraglutyd (agoniści receptora GLP)
  • CSTI-500 (potrójny inhibitor wychwytu zwrotnego monoamin)
  • Oksytocyna i karbekocyna (leczenie podobne do oksytocyny)
  • Setmelanotyd (badania kliniczne fazy 2)
  • Pitolisant (badania kliniczne fazy 2)

Aktywność fizyczna

Zwiększona aktywność fizyczna i regularne ćwiczenia są kluczowe dla zarządzania wagą u pacjentów z PWS. Zaleca się zachęcanie do aktywności fizycznej w domu, w szkole (np. zwiększone okresy wychowania fizycznego) oraz w społeczności (np. Olimpiady Specjalne).4735

U pacjentów z PWS ćwiczenia mogą pomóc w:48

  • Ochronie przed utratą mięśni
  • Utrzymaniu siły kości
  • Zarządzaniu wagą
  • Poprawie codziennej aktywności
  • Utrzymaniu i poprawie ogólnej mobilności
  • Zachowaniu jakości życia

Kontrola dostępu do żywności

Opiekunowie muszą wdrażać fizyczne bariery, takie jak zamykanie szafek z jedzeniem i lodówek, oraz ścisły nadzór, aby egzekwować ograniczenia żywieniowe. Osoby z hiperfagią mogą zaniedbywać dokładne żucie pokarmów, co zwiększa ryzyko zadławienia, dlatego bardzo ważne jest przeszkolenie opiekunów w zakresie manewru Heimlicha.4936

Terapie wspomagające

Fizjoterapia

Pacjenci z zespołem Pradera-Williego wykazują obniżone napięcie mięśniowe i wymagają dodatkowej terapii zajęciowej i fizycznej w celu wspierania nabywania umiejętności motorycznych i wzmacniania mięśni kręgosłupa, aby zminimalizować skoliozę.5051

Fizjoterapia powinna koncentrować się na:5248

  • Poprawie równowagi, koordynacji i siły
  • Rozwijaniu umiejętności motorycznych, takich jak podnoszenie głowy, siedzenie, czołganie się i chodzenie
  • Zwiększeniu wytrzymałości
  • Poprawie mobilności

Fizjoterapeuci mogą świadczyć usługi lecznicze w domu, w szkole lub w poradni ambulatoryjnej. Celem fizjoterapii jest poprawa siły, wytrzymałości, koordynacji i ruchu.48

Terapia zajęciowa

Terapia zajęciowa pomaga przede wszystkim w rozwoju umiejętności motorycznych i kontroli dłoni. Terapeuci zajęciowi przeprowadzają również działania pomagające w integracji sensorycznej i mogą wykonywać ćwiczenia motoryki jamy ustnej w celu poprawy siły ssania w przygotowaniu do mowy.5253

Terapia logopedyczna

Wczesna ocena i interwencja są niezbędne dla rozwoju funkcjonalnej komunikacji. Rodzicom zdecydowanie zaleca się rozpoczęcie terapii motoryki jamy ustnej w niemowlęctwie, aby pomóc w karmieniu i nabywaniu umiejętności motorycznych jamy ustnej niezbędnych do gaworzenia i mowy.5453

Terapia logopedyczna może wspierać:5556

  • Zwiększenie zrozumiałości mowy
  • Rozwijanie języka ekspresyjnego (używanie) i receptywnego (rozumienie)
  • Rozwijanie umiejętności motorycznych jamy ustnej związanych z karmieniem

Inne formy terapii

Dla pacjentów z PWS korzystne mogą być również inne terapie:5457

  • Hipoterapia – zazwyczaj zalecana dla dzieci w wieku od 2 lat. Rytmiczne, powtarzalne ruchy konia działają na poprawę napięcia mięśniowego, równowagi, postawy, koordynacji, siły, elastyczności i umiejętności poznawczych.
  • Masaż niemowlęcy – korzystny dla poprawy krążenia krwi, wspomagania trawienia, zwiększenia rozwoju układu nerwowego, stymulacji rozwoju neurologicznego, zwiększenia czujności i poprawy funkcji immunologicznych.
  • Terapia rekreacyjna, muzykoterapia, arteterapia i zooterapia.

Leczenie zaburzeń behawioralnych i psychicznych

Terapia behawioralna

Większość pacjentów z zespołem Pradera-Williego doświadcza problemów behawioralnych lub diagnoz psychiatrycznych, przy czym około jedna czwarta dzieci spełnia kryteria diagnostyczne zaburzeń ze spektrum autyzmu.5859

Strategie behawioralne pomagają pacjentom zrozumieć zasady, harmonogramy, oczekiwania i wskazówki werbalne, minimalizując objawy kompulsji i agresji. Regularne rutyny, jasne zasady i pozytywne nagrody mogą pomóc w zarządzaniu tymi problemami.5856

Terapia poznawczo-behawioralna (CBT) jest cennym podejściem terapeutycznym do zarządzania problemami behawioralnymi związanymi z zespołem Pradera-Williego. CBT pomaga identyfikować i zmieniać szkodliwe zachowania.5560

Farmakoterapia zaburzeń psychicznych

Nastolatki i dorośli z zaburzeniami nastroju lub psychozami mogą wymagać leków i terapii. Wiele leków stosowano w celu modyfikacji zachowania, ale mają one tendencję do bycia nieskutecznymi lub wręcz przeciwskutecznymi.5861

Do leków stosowanych w leczeniu objawów behawioralnych PWS należą:6261

  • Selektywne inhibitory wychwytu zwrotnego serotoniny (SSRI), takie jak fluoksetyna – mogą zmniejszać niepokój, stabilizować zachowanie lub leczyć depresję
  • Olanzapina – może mieć pewien efekt na zachowanie
  • Haloperidol – czasami skuteczny
  • Lit – może być jednym z najbardziej skutecznych długoterminowych metod stabilizacji nastroju
  • Kwas walproinowy – stosowany czasami do leczenia epizodów maniakalnych i stabilizacji nastroju w PWS
  • Topiramat w niskich dawkach – skuteczny w leczeniu samookaleczania (drapania skóry) i zachowań impulsywnych/agresywnych

SSRI wydają się mieć niespecyficzny efekt stabilizujący zachowanie, z mniejszą liczbą wybuchów, wyraźnym zmniejszeniem drażliwości i mniejszą perseweracją, ale bez efektu przeciwdepresyjnego.61

Badanie wykazało również korzyści z leczenia drapania skóry (częsty problem u pacjentów z PWS) doustną guanfacyną.58

Leczenie powikłań i chorób współistniejących

Zaburzenia snu

Leczenie bezdechu sennego i innych zaburzeń snu może zmniejszyć senność w ciągu dnia i problemy behawioralne. Pacjenci doświadczający senności w ciągu dnia i problemów z zachowaniem powinni być badani pod kątem obturacyjnego bezdechu sennego (OSA), a w niektórych przypadkach konieczna może być interwencja chirurgiczna w postaci tonsilektomii lub adenotonsilektomii. Może być również konieczne stosowanie aparatu CPAP (continuous positive airway pressure).516364

Melatonina może poprawić jakość snu i pomóc przy wczesnym budzeniu się u niektórych dzieci z PWS.62

Problemy ortopedyczne

Obniżona gęstość mineralna kości jest typowa dla pacjentów z PWS, dlatego powinni oni przechodzić ocenę za pomocą badań DXA co 2-3 lata, począwszy od 5 roku życia.58

Skolioza jest również powszechna, dlatego zaleca się monitorowanie pacjentów pediatrycznych podczas rutynowych wizyt i kierowanie ich na ocenę ortopedyczną, gdy jest to wskazane. Leczenie skoliozy może obejmować gipsowanie, ortezowanie, fizjoterapię i operację.5865

Jeśli krzywizna kręgosłupa przekracza około 40-50°, wymagana jest operacja skoliozy. Spondylodeza jest opcją leczniczą skoliozy, ale u młodszych dzieci (do 10 roku życia) operacja mogłaby trwale ograniczyć wzrost kręgosłupa i klatki piersiowej. Alternatywnie, chirurdzy ortopedzi mogą zastosować rozszerzalne implanty w celu skorygowania krzywizny kręgosłupa i umożliwienia wzrostu kości.66

Problemy metaboliczne i endokrynologiczne

Może również wystąpić niedoczynność tarczycy, dlatego zalecane jest rozpoczęcie rutynowych badań w pierwszym roku życia. Cukrzyca typu 2 może pojawić się jako powikłanie ciężkiej otyłości, dlatego należy przeprowadzać badania przesiewowe, jeśli są wskazania.63

Suplementy mogą zwiększyć niski poziom wapnia i witaminy D, które są ważne dla zdrowia kości.67

Problemy okulistyczne

Pacjenci z nieprawidłowymi wynikami badania wzroku mogą wymagać okularów korekcyjnych lub operacji. Problemy ze wzrokiem, takie jak krótkowzroczność czy dalekowzroczność, są częste u pacjentów z PWS.647

Nowe kierunki w leczeniu zespołu Pradera-Williego

Badania kliniczne

Badania kliniczne pomagają naukowcom opracowywać leki do leczenia zespołu Pradera-Williego. Kiedy dziecko uczestniczy w badaniu klinicznym, przyczynia się do rozwoju opcji leczenia dla osób żyjących z PWS.68

W fazie 2 badań klinicznych lek jest testowany na większej grupie osób z określonym schorzeniem, jak zespół Pradera-Williego. Nacisk kładzie się na ocenę jego skuteczności i monitorowanie działań niepożądanych. W fazie 3 lek jest porównywany z obecnymi standardami lub placebo. Celem jest dalsza ocena jego skuteczności, bezpieczeństwa i korzyści w porównaniu z innymi opcjami.68

Neuromodulacja

Alternatywą dla stosowania leków jako terapii jest wykorzystanie urządzeń do stymulacji aktywności mózgu w określonych regionach. Różne nieinwazyjne i inwazyjne metody neuromodulacji opartej na urządzeniach, w tym stymulacja nerwu błędnego (VNS), przezczaszkowa stymulacja prądem stałym (tDCS), powtarzalna przezczaszkowa stymulacja magnetyczna (rTMS) i głęboka stymulacja mózgu (DBS), były zgłaszane jako potencjalnie obiecujące metody leczenia głównych objawów PWS.6970

Terapia genowa

Terapia genowa modyfikuje DNA i pozostaje eksperymentalną techniką w świecie badań medycznych, ale ma nadzieję, że techniki terapii genowej będą wykorzystywane w przyszłości do leczenia zaburzeń bez potrzeby stosowania leków czy operacji.71

Dr Yong-hui Jiang przebadał tysiące związków lekowych w poszukiwaniu małych cząsteczek, które mogłyby aktywować ekspresję genów PWS w komórkach pochodzących od myszy z PWS i znalazł dwa związki, które wydają się mieć tę zdolność: UNC0638 i UNC0642.7172

Terapia oksytocyną

Badanie podwójnie ślepe, kontrolowane placebo, krzyżowe przeprowadzone przez Miller i wsp. sugeruje, że terapia oksytocyną donosową w niskich dawkach może zmniejszyć popęd apetytu u pacjentów z zespołem Pradera-Williego, a także poprawić socjalizację, lęk i zachowania powtarzalne u tych osób.7374

Inny badanie oceniało skuteczność donosowej oksytocyny u dzieci z PWS i wykazało tendencję do poprawy kilku parametrów behawioralnych, w tym drażliwości, letargu, stereotypii i nadaktywności, a także znaczącą poprawę ogólnego wyniku SRS w 6 dniu po leczeniu.75

Tauber i współpracownicy donieśli, że oksytocyna może pomóc zwiększyć zaufanie do innych i zmniejszyć destrukcyjne zachowania u pacjentów z PWS, a także znacząco poprawić umiejętności społeczne i karmienie u niemowląt z PWS.76

Wczesne leczenie oksytocyną u niemowląt z PWS jest bezpieczne do 3-4 lat. Dzieci eksponowane na oksytocynę wykazują lepsze wyniki społeczne, endokrynologiczne i metaboliczne. Badanie dokumentuje po raz pierwszy u ludzi biologiczne okno możliwości wczesnego leczenia oksytocyną, które może zmienić trajektorię stanu PWS.77

Kompleksowe programy terapeutyczne dla pacjentów z PWS

Program Jump Start

Jump Start to program przeznaczony dla młodych ludzi z ustalonymi problemami z kontrolą wagi, w tym z zespołem Pradera-Williego. Program oferuje strukturalne, środowisko szpitalne, w którym dzieci otrzymują opiekę medyczną, wsparcie i wskazówki, których potrzebują, aby osiągnąć cele związane z utratą wagi i ogólnym stanem zdrowia.7879

Cele programu obejmują:7880

  • Zmniejszenie wskaźnika masy ciała (BMI)
  • Zwiększenie mobilności fizycznej
  • Rozwiązywanie stanów związanych z wagą
  • Rozwijanie strategii zarządzania zachowaniem
  • Poprawę ogólnej jakości życia

Podczas pobytu pacjenci dostosowują się do spersonalizowanych diet kontrolowanych pod względem kalorii, uczą się ustalania harmonogramów i rozwijają siłę fizjologiczną i emocjonalną poprzez terapie fizyczne, zajęciowe, logopedyczne, rekreacyjne, muzyczne i oparte na zwierzętach.80

Wielospecjalistyczne kliniki PWS

Specjalistyczne kliniki PWS, takie jak te prowadzone przez renomowane instytucje medyczne, oferują kompleksową opiekę dla pacjentów z PWS. Kliniki te skupiają zespoły ekspertów, którzy zapewniają:818283

  • Wczesną interwencję dla każdego dziecka
  • Indywidualne podejście do diagnozowania i leczenia możliwych powikłań
  • Koordynację terapii hormonem wzrostu i innymi hormonami
  • Poradnictwo żywieniowe i zalecenia
  • Pomoc w opracowaniu planu opieki żywieniowej dostosowanego do potrzeb każdej rodziny
  • Wsparcie w radzeniu sobie z trudnościami behawioralnymi/emocjonalnymi
  • Ciągłe wsparcie w radzeniu sobie/dostosowaniu do PWS przez całe życie

Podsumowanie aktualnych strategii leczenia PWS

Leczenie zespołu Pradera-Williego wymaga kompleksowego, wielodyscyplinarnego podejścia, które powinno rozpocząć się jak najwcześniej po diagnozie. Choć nie istnieje lekarstwo na PWS, dostępne są różnorodne metody terapeutyczne, które mogą znacząco poprawić jakość życia pacjentów.818

Kluczowe elementy leczenia PWS obejmują:784

  • Terapię hormonem wzrostu – podstawę leczenia, szczególnie u dzieci
  • Leczenie hormonami płciowymi w okresie dojrzewania
  • Ścisłą kontrolę diety i aktywność fizyczną
  • Terapie wspomagające: fizjoterapię, terapię zajęciową, logopedię
  • Leczenie zaburzeń behawioralnych i psychicznych
  • Monitorowanie i leczenie chorób współistniejących

Nowe kierunki w leczeniu PWS, takie jak farmakoterapia hiperfagii (w tym niedawno zatwierdzony diazoksyd choliny), neuromodulacja, terapia genowa i terapia oksytocyną, dają nadzieję na poprawę zarządzania objawami w przyszłości.7144

Wczesna diagnoza i wielokierunkowe leczenie pozostają kluczowe dla poprawy jakości życia pacjentów z zespołem Pradera-Williego.8

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 09.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China | Orphanet Journal of Rare Diseases | Full Text
    https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02302-z
    Prader-Willi syndrome (PWS) is a complex and multisystem neurobehavioral disease, which is caused by the lack of expression of paternally inherited imprinted genes on chromosome15q11.2-q13.1. […] Therefore, there is an urgent need for an integrated multidisciplinary approach to facilitate early diagnosis and optimize management to improve quality of life, prevent complications, and prolong life expectancy. […] Early diagnosis and treatment can significantly improve the prognosis. […] Management of the manifestations of PWS depends on age and should include guidance to manage the consequences and expectations of the syndrome. Multidisciplinary treatment has been shown to reduce hospital stays and prevent early obesity. […] Recombinant human GH (rhGH) therapy in patients with PWS has been used by the medical community since its approval in the United States in 2000 and in Europe in 2001.
  • #2 Prader-Willi Syndrome | Effective Health Care (EHC) Program
    https://effectivehealthcare.ahrq.gov/health-topics/prader-willi-syndrome
    Prader-Willi Syndrome (PWS) is a rare genetic disorder. It causes poor muscle tone, low levels of sex hormones and a constant feeling of hunger. The part of the brain that controls feelings of fullness or hunger does not work properly in people with PWS. They overeat, leading to obesity. […] There is no cure for PWS. Growth hormone, exercise, and dietary supervision can help build muscle mass and control weight. Other treatments may include sex hormones and behavior therapy. Most people with PWS will need specialized care and supervision throughout their lives.
  • #3 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-treatment
    A multinational study by Hughes et al indicated that persons with Prader-Willi syndrome can benefit from 24-hour professional support, including with regard to weight/body mass index reduction and improvement in behaviors of concern (ie, temper outbursts, skin picking, egocentrism, inflexibility, striving for dominance). […] Patients with Prader-Willi syndrome frequently require medical care for the following: initial management of hypotonia or poor feeding, evaluation for hypogonadism or hypopituitarism, management of sleep-related concerns – Central apnea, obstructive apnea, daytime somnolence, management of obesity, monitoring for scoliosis, therapy for behavioral issues. […] In March 2025, the US Food and Drug Administration (FDA) approved diazoxide choline (Vykat XR) as the first drug for the treatment of hyperphagia in Prader-Willi syndrome.
  • #4 Prader-Willi syndrome – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/prader-willi-syndrome/diagnosis-treatment/drc-20356002
    Early diagnosis and treatment can make quality of life better for people with Prader-Willi syndrome. A team of health professionals likely will manage the condition. […] Your child’s team may include a doctor who treats hormonal conditions, also known as an endocrinologist, as well as a behavior specialist, a dietitian, physical and occupational therapists, a speech and language therapist, a mental health professional, a geneticist, and other specialists. […] Although specific treatments vary depending on symptoms, most children with Prader-Willi syndrome will need: […] Good nutrition. Many infants with Prader-Willi syndrome have a hard time feeding because they have less muscle tone. Your child’s healthcare professional may recommend a high-calorie formula or special feeding methods to help your baby gain weight. They will monitor your child’s growth.
  • #5 Guide | Physical Therapy Guide to Prader-Willi Syndrome | Choose PT
    https://www.choosept.com/guide/physical-therapy-guide-prader-willi-syndrome
    Physical therapists work with children who have PWS and their families to address physical, mental, and behavioral challenges. […] Physical therapists are movement experts. They improve quality of life through hands-on care, patient education, and prescribed movement. […] With careful weight management strategies and a good support system, people with PWS can remain healthy and live a normal lifespan. […] People with PWS have the best chance for managing their weight successfully and an increasing lifespan with: Healthy diet and nutritional education, Controlled access to food, Growth hormone treatment, Exercise programs, Early diagnosis, especially in the newborn period. […] Managing PWS includes: Proper diet, Exercise, Growth hormone treatments, Strategies to address behavior and learning problems.
  • #5 Prader Willi Syndrome Clinic
    https://www.nationwidechildrens.org/specialties/prader-willi-syndrome-clinic
    Prader-Willi Syndrome (PWS) is treated at Nationwide Childrens Hospital by a team of dedicated pediatric experts. […] We focus on early intervention for every child. From newborns to young adults, our team works with you to create an individualized approach to diagnose and treat possible complications that can be associated with PWS. […] The expert pediatric care team includes an endocrine nurse coordinator, endocrinologists, a geneticist, a genetic counselor, neurologist, psychologist, dietitian and social worker who attend each PWS Clinic. […] Assists families with all aspects of growth hormone therapy. […] Determines age appropriate and individual treatment plans for your child. […] Directs growth hormone therapy and other endocrine replacement hormones. […] Discusses specialized care needs with families and the PWS team.
  • #6 What Treatments are available for Prader-Willi Syndrome? – Prader-Willi Syndrome Association of Victoria, Australia
    https://pwsavic.org.au/information/what-treatments-are-available-for-prader-willi-syndrome/
    People with Prader-Willi Syndrome (PWS) are affected from birth throughout all stages of their life. […] The treatment of PWS is currently based on treating the symptoms of the disorder as they arise. […] A holistic and multidisciplinary approach starting from the neonatal period is recommended to ensure optimal management to improve the quality of life of Prader-Willi Syndrome patients throughout their lifetime. […] Research has shown that Holistic care and integrated services deliver better outcomes for people with Prader-Willi Syndrome. […] There is no medication available to cure Prader-Willi Syndrome. Still, there are viable treatments, interventions and management strategies to assist with many of the symptoms/characteristics of Prader-Willi Syndrome. […] Treatment aims to ease some of the associated problems. Depending on the needs of the person, some of the treatment options may include: strict supervision of diet (there are no medical means of curbing appetite), plenty of physical activity to help maintain the child’s body weight within the normal range, growth hormone treatment to overcome the hormone deficiency that contributes to the child’s short stature, hormone therapy to increase muscle mass, hormone therapy to boost inadequate sex hormone levels, medication to help control any obsessive and compulsive behaviours, orthopaedic treatment for scoliosis or kyphosis, appropriate prescription eyeglasses, specialist care from a range of healthcare professionals.
  • #6 Prader-Willi syndrome – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/prader-willi-syndrome/symptoms-causes/syc-20355997
    A team of different types of specialists can best manage the symptoms of Prader-Willi syndrome. The team approach to this complex condition makes complications less likely and improves quality of life. […] A genetic counselor can help figure out the risk of having another child with Prader-Willi syndrome. […] If you have a child with Prader-Willi syndrome and would like to have another baby, think about getting genetic counseling. A genetic counselor can help you figure out the risk of having another child with Prader-Willi syndrome. […] Prader-Willi syndrome: Endocrine manifestations and management. […] A multidisciplinary approach to the clinical management of Prader-Willi syndrome.
  • #7 What Treatments are available for Prader-Willi Syndrome? – Prader-Willi Syndrome Association of Victoria, Australia
    https://pwsavic.org.au/information/what-treatments-are-available-for-prader-willi-syndrome/
    People with Prader-Willi Syndrome (PWS) are affected from birth throughout all stages of their life. […] The treatment of PWS is currently based on treating the symptoms of the disorder as they arise. […] A holistic and multidisciplinary approach starting from the neonatal period is recommended to ensure optimal management to improve the quality of life of Prader-Willi Syndrome patients throughout their lifetime. […] Research has shown that Holistic care and integrated services deliver better outcomes for people with Prader-Willi Syndrome. […] There is no medication available to cure Prader-Willi Syndrome. Still, there are viable treatments, interventions and management strategies to assist with many of the symptoms/characteristics of Prader-Willi Syndrome. […] Treatment aims to ease some of the associated problems. Depending on the needs of the person, some of the treatment options may include: strict supervision of diet (there are no medical means of curbing appetite), plenty of physical activity to help maintain the child’s body weight within the normal range, growth hormone treatment to overcome the hormone deficiency that contributes to the child’s short stature, hormone therapy to increase muscle mass, hormone therapy to boost inadequate sex hormone levels, medication to help control any obsessive and compulsive behaviours, orthopaedic treatment for scoliosis or kyphosis, appropriate prescription eyeglasses, specialist care from a range of healthcare professionals.
  • #8 Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China | Orphanet Journal of Rare Diseases | Full Text
    https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02302-z
    Prader-Willi syndrome (PWS) is a complex and multisystem neurobehavioral disease, which is caused by the lack of expression of paternally inherited imprinted genes on chromosome15q11.2-q13.1. […] Therefore, there is an urgent need for an integrated multidisciplinary approach to facilitate early diagnosis and optimize management to improve quality of life, prevent complications, and prolong life expectancy. […] Early diagnosis and treatment can significantly improve the prognosis. […] Management of the manifestations of PWS depends on age and should include guidance to manage the consequences and expectations of the syndrome. Multidisciplinary treatment has been shown to reduce hospital stays and prevent early obesity. […] Recombinant human GH (rhGH) therapy in patients with PWS has been used by the medical community since its approval in the United States in 2000 and in Europe in 2001.
  • #9 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-treatment
    On June 20, 2000, the FDA approved the use of growth hormone in children with genetically confirmed Prader-Willi syndrome and evidence of growth failure. […] A study by Bakker et al indicated that growth hormone therapy improves the health-related quality of life (HRQOL) in children with Prader-Willi syndrome. […] A prospective cohort study by Donze et al reported that in infants and toddlers with Prader-Willi syndrome who underwent 3 years of growth hormone therapy, mental and motor development tended to see a greater increase in patients who began treatment at a younger age and who had lower psychomotor development at baseline. […] A study by Scheermeyer et al indicated that in infants (aged 2-12 mo) with Prader-Willi syndrome, the effects of low-dose growth hormone treatment (4.5 mg/m2/wk) on growth and development are comparable to those of higher-dose treatment (7 mg/m2/wk).
  • #10 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    In March 2025, the US Food and Drug Administration (FDA) approved diazoxide choline (Vykat XR) as the first drug for the treatment of hyperphagia in Prader-Willi syndrome. […] On June 20, 2000, the FDA approved the use of growth hormone in children with genetically confirmed Prader-Willi syndrome and evidence of growth failure. A study by Bakker et al indicated that growth hormone therapy improves the health-related quality of life (HRQOL) in children with Prader-Willi syndrome. […] A prospective cohort study by Donze et al reported that in infants and toddlers with Prader-Willi syndrome who underwent 3 years of growth hormone therapy, mental and motor development tended to see a greater increase in patients who began treatment at a younger age and who had lower psychomotor development at baseline.
  • #11 Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome – Journal of Clinical Research in Pediatric Endocrinology
    https://www.jcrpe.org/articles/clinical-characteristics-and-growth-hormone-treatment-in-patients-with-prader-willi-syndrome/doi/jcrpe.galenos.2021.2020.0228
    Objective: To investigate clinical characteristics and response to growth hormone (GH) treatment in patients with Prader-Willi syndrome (PWS) in Turkey. […] GH treatment was started in 40% at a mean age of 4.72.7 years. After two years of GH treatment, a significant increase in height SDS was observed. However, body mass index (BMI) standard deviation (SDS) remained unchanged. […] GH deficiency is very common in PWS. Recombinant human GH (rGH) is indicated in the treatment of growth failure in PWS and provocation testing to demonstrate GH deficiency is unnecessary for patients with genetically confirmed PWS. In addition, treatment with GH can improve body composition and physical strength, as well as motor and mental development. […] The rationale for treating PWS children with GH is to not only to enhance linear growth but also to improve body composition, energy expenditure and muscle strength.
  • #12 What are the treatments for Prader-Willi syndrome (PWS)? | NICHD – Eunice Kennedy Shriver National Institute of Child Health and Human Development
    https://www.nichd.nih.gov/health/topics/prader-willi/conditioninfo/treatments
    Parents can enroll infants with PWS in early intervention programs. However, even if a PWS diagnosis is delayed, treatments are valuable at any age. […] The types of treatment depend on the individuals symptoms. The healthcare provider may recommend the following: […] Use of special nipples or tubes for feeding difficulties. […] Strict supervision of daily food intake. Once overeating starts between ages 2 and 4 years, supervision will help to minimize food hoarding and stealing and prevent rapid weight gain and severe obesity. […] Growth Hormone (GH) therapy. GH therapy has been demonstrated to increase height, lean body mass, and mobility; decrease fat mass; and improve movement and flexibility in individuals with PWS from infancy through adulthood. […] Treatment of eye problems by a pediatric ophthalmologist.
  • #13 What Treatments are available for Prader-Willi Syndrome? – Prader-Willi Syndrome Association of Victoria, Australia
    https://pwsavic.org.au/information/what-treatments-are-available-for-prader-willi-syndrome/
    A group of clinicians have established a series of guidelines for the treatment of people with Prader-Willi syndrome. […] Growth Hormone is effective in increasing height, increasing muscle mass, decreasing body fat, improving weight distribution, increasing stamina and increasing bone mineral density.
  • #14 Prader-Willi Syndrome (PWS): Symptoms & Causes | NewYork-Presbyterian
    https://www.nyp.org/pediatrics/prader-willi-syndrome/treatment
    There is no cure for Prader-Willi syndrome, but there are many ways to manage symptoms. A team of specialists will develop a treatment plan. The healthcare team could include a clinical geneticist, pediatrician, orthopedist, endocrinologist, speech therapist, psychologist, dietician, nutritionist, etc. […] Therapies vary depending on an individuals symptoms and how severe they are. Approaches used for treatment of Prader-Willi syndrome that can help ensure a good quality of life include: […] Growth hormone therapy to increase height, decrease body fat, improve muscle tone and improve bone density […] Early intervention to assess motor skills, cognition, and speech and language development and provide physical and occupational therapy and other services as needed, including an individualized education plan at school […] Low-calorie diet, regular exercise, and supervised eating to manage weight while ensuring proper nutrition, ideally before signs of obesity develop […] Sex hormone replacement at puberty to develop secondary sexual characteristics and improve bone density.
  • #15 Prader-Willi syndrome and growth hormone therapy: exploring the precise management of hypothalamic short stature: A review
    https://www.pfmjournal.org/journal/view.php?doi=10.23838/pfm.2023.00079
    Currently, in Korea, GHT for patients with PWS is covered by insurance, starting from the age of 2 years. Furthermore, most experts agree on initiating GHT before the onset of obesity, often setting the target age at 2 years of age. […] The advantages of GHT in PWS are as follows and have been demonstrated in numerous observational studies and RCTs. […] Enhanced motor development: a meta-analysis of five randomized trials involving 154 infants and children with PWS (aged 1.3 to 3 years) found that those receiving recombinant human growth hormone (rhGH) treatment demonstrated higher scores on standardized motor development tests. […] Enhanced cognitive development: in the same trial involving infants and toddlers, rhGH therapy also demonstrated improvements in cognitive development during the first year of treatment.
  • #16 Prader-Willi syndrome and growth hormone therapy: exploring the precise management of hypothalamic short stature: A review
    https://www.pfmjournal.org/journal/view.php?doi=10.23838/pfm.2023.00079
    Currently, in Korea, GHT for patients with PWS is covered by insurance, starting from the age of 2 years. Furthermore, most experts agree on initiating GHT before the onset of obesity, often setting the target age at 2 years of age. […] The advantages of GHT in PWS are as follows and have been demonstrated in numerous observational studies and RCTs. […] Enhanced motor development: a meta-analysis of five randomized trials involving 154 infants and children with PWS (aged 1.3 to 3 years) found that those receiving recombinant human growth hormone (rhGH) treatment demonstrated higher scores on standardized motor development tests. […] Enhanced cognitive development: in the same trial involving infants and toddlers, rhGH therapy also demonstrated improvements in cognitive development during the first year of treatment.
  • #17 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-treatment
    A consensus group made up of clinicians from the United Kingdom and the Republic of Ireland with extensive experience in Prader-Willi syndrome devised recommendations on the conditions management in children up to age 18 years. […] The consensus group also states that after a sleep study is obtained, growth hormone should be recommended to start prior to the age of 1 year. […] In addition, the group recommends that in patients under age 5 years on growth hormone therapy, a level 2 sleep study be performed at least every 2-3 years, with such studies run sooner if there is a clinical suggestion of worsening obstructive sleep apnea. […] According to the consensus group, in adults with Prader-Willi syndrome, growth hormone therapy can be used up to age 25 years, but that after that, the data supporting this intervention are sparse.
  • #18
    https://www.nhs.uk/conditions/prader-willi-syndrome/living-with/
    There’s no cure for Prader-Willi syndrome, but your child will have support from healthcare professionals who will help you manage the condition. […] The treatment plan will be continually reassessed as your child gets older and their needs change. […] A dietitian can give you information about what food to give. […] Some medicines have been used to try to suppress appetites, but have all been unsuccessful. […] Weight loss surgery is not recommended for people with Prader-Willi syndrome because they are not able to stick to the strict diet required after surgery. […] Treatment with an artificial version of the human growth hormone (HGH) is usually recommended for children with Prader-Willi syndrome. […] Starting treatment with HGH is usually recommended during early childhood, from 6 months to 2 years of age, and normally continues until the end of growth.
  • #19 Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China | Orphanet Journal of Rare Diseases | Full Text
    https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02302-z
    No consensus was reached on the age of starting rhGH treatment, although all agreed to the benefits of treating before the onset of obesity. […] Before initiation of rhGH therapy, patients with PWS should have a confirmed molecular diagnosis and expert multidisciplinary evaluation. […] It seems that GH treatment is generally safe and well tolerated. […] The early treatment of hypogonadism (within the first 6 months of life) is beneficial to many male patients with PWS. […] At present, the management of PWS is based on symptoms. […] Routine vaccination is recommended for patients with PWS when their conditions are stable and there are no other contraindications, such as severe malnutrition or infection.
  • #20 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    A study by Scheermeyer et al indicated that in infants (aged 2-12 mo) with Prader-Willi syndrome, the effects of low-dose growth hormone treatment (4.5 mg/m2/wk) on growth and development are comparable to those of higher-dose treatment (7 mg/m2/wk). […] A consensus group made up of clinicians from the United Kingdom and the Republic of Ireland with extensive experience in Prader-Willi syndrome devised recommendations on the conditions management in children up to age 18 years. Among these, the consensus group lists as mandatory the performance of a level 2 (cardio-respiratory) sleep study prior to the administration of growth hormone therapy, owing to the potential for growth hormone-associated upper respiratory changes to occur. […] The consensus group also states that after a sleep study is obtained, growth hormone should be recommended to start prior to the age of 1 year.
  • #21 Prader-Willi syndrome: Update on treatment by growth hormone | Anales de Pediatría
    https://analesdepediatria.org/es-prader-willi-syndrome-update-on-treatment-articulo-13031043
    GH treatment for PWS is a major advance both in the management of these children and in our knowledge of the pathophysiology of the syndrome, and it also stimulates the motivation of the care team and the families. […] The growth hormone commercialized by Pharmacia Laboratoires received its European marketing license in 2000 for the treatment of PWS and neglected disorders. […] The recommended dose is the same as that used in the treatment of GH deficiencies: 0.7 IU/kg/week (0.23 mg/kg/ week). […] So today, in Europe, children with PWS can be treated with GH even if they do not have GH deficiency or growth retardation. […] Recommendations will very certainly be formulated in the near future and a consensus is needed. […] GH treatment for PWS is a major advance both in the management of these children and in our knowledge of the pathophysiology of the syndrome, and it also stimulates the motivation of the care team and the families.
  • #22 Prader-Willi syndrome and growth hormone therapy: exploring the precise management of hypothalamic short stature: A review
    https://www.pfmjournal.org/journal/view.php?doi=10.23838/pfm.2023.00079
    Improved growth and body composition: previous studies consistently show that rhGH therapy enhances linear growth and positively impacts body composition and obesity, regardless of whether treatment starts in infancy or later in childhood. […] The most substantial response to rhGH therapy in PWS children typically occurs within the initial 12 months of treatment. […] However, sustained enhancements in height, bone density, and body composition have been observed with extended rhGH treatment, spanning up to 5 years. […] Although GH replacement therapy has demonstrated general tolerability and has been extensively documented over the last 20 years, fatal events within the initial months of GH treatment have been reported in young patients with PWS. […] To ensure the safety of early initiation of GHT, thorough pretreatment assessments, including sleep studies, evaluations of the ear-nose-throat region, and thyroid function tests, are necessary.
  • #23 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-treatment
    A consensus group made up of clinicians from the United Kingdom and the Republic of Ireland with extensive experience in Prader-Willi syndrome devised recommendations on the conditions management in children up to age 18 years. […] The consensus group also states that after a sleep study is obtained, growth hormone should be recommended to start prior to the age of 1 year. […] In addition, the group recommends that in patients under age 5 years on growth hormone therapy, a level 2 sleep study be performed at least every 2-3 years, with such studies run sooner if there is a clinical suggestion of worsening obstructive sleep apnea. […] According to the consensus group, in adults with Prader-Willi syndrome, growth hormone therapy can be used up to age 25 years, but that after that, the data supporting this intervention are sparse.
  • #24 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    A study by Scheermeyer et al indicated that in infants (aged 2-12 mo) with Prader-Willi syndrome, the effects of low-dose growth hormone treatment (4.5 mg/m2/wk) on growth and development are comparable to those of higher-dose treatment (7 mg/m2/wk). […] A consensus group made up of clinicians from the United Kingdom and the Republic of Ireland with extensive experience in Prader-Willi syndrome devised recommendations on the conditions management in children up to age 18 years. Among these, the consensus group lists as mandatory the performance of a level 2 (cardio-respiratory) sleep study prior to the administration of growth hormone therapy, owing to the potential for growth hormone-associated upper respiratory changes to occur. […] The consensus group also states that after a sleep study is obtained, growth hormone should be recommended to start prior to the age of 1 year.
  • #25 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    In addition, the group recommends that in patients under age 5 years on growth hormone therapy, a level 2 sleep study be performed at least every 2-3 years, with such studies run sooner if there is a clinical suggestion of worsening obstructive sleep apnea. […] According to the consensus group, in adults with Prader-Willi syndrome, growth hormone therapy can be used up to age 25 years, but that after that, the data supporting this intervention are sparse. […] A double-blind, placebo-controlled, crossover study by Miller et al suggested that low-dose intranasal oxytocin therapy may reduce appetite drive in patients with Prader-Willi syndrome, as well as improve socialization, anxiety, and repetitive behaviors in these individuals. […] Patients with Prader-Willi syndrome may require operative care for treatment of complications of obesity, treatment of cryptorchidism, and treatment of sleep apnea, as well as for scoliosis intervention.
  • #26 Prader-Willi syndrome and growth hormone therapy: exploring the precise management of hypothalamic short stature: A review
    https://www.pfmjournal.org/journal/view.php?doi=10.23838/pfm.2023.00079
    GH treatment is not recommended for individuals with severe obesity, uncontrolled diabetes, or pre-existing severe scoliosis. […] GH treatment for adults with PWS offers potential benefits, such as improved body composition, muscle strength, metabolic health, cognition, and quality of life. […] The efficacy and safety of GHT in adult patients with PWS remain controversial, with research suggesting its benefits in various areas. […] Ongoing research on PWS explores innovative treatment modalities beyond GHT. Interventions targeting appetite regulation, metabolic pathways, and behavioral aspects are being investigated to complement GHT and enhance the overall management of PWS. […] GH injection therapy has demonstrated beneficial effects on motor and cognitive development, growth, and body composition in individuals with PWS.
  • #27 Treatment with growth hormone in the Prader-Willi syndrome | Endocrinología, Diabetes y Nutrición (English ed.)
    https://www.elsevier.es/en-revista-endocrinologia-diabetes-nutricion-english-ed–413-articulo-treatment-with-growth-hormone-in-S2530018018300581
    Treatment with growth hormone in the Prader-Willi syndrome […] Recombinant GH (rGH) is effective in children and represents the mainstay in treatment; by contrast, little evidence in available in adult patients. […] In pediatric and adult PWS, rGH improves body morphology and composition, physical performance, cognition, psychomotor development, respiratory function, and quality of life with few adverse effects. […] Treatment with rGH is effective and safe and improves quality of life in both children and adults with PWS. […] Treatment proceeds gradually until the usual dose of 1mg/m2/day (0.035mg/kg/day) is reached. […] By contrast, treatment in adults should only be started with a diagnosis of GHD. […] The effects of rGH therapy upon linear growth in children have been well established.
  • #28 Effects of Childhood Multidisciplinary Care and Growth Hormone Treatment on Health Problems in Adults with Prader-Willi Syndrome
    https://www.mdpi.com/2077-0383/10/15/3250
    In adults with PWS, GH treatment improves body composition (by increasing lean body mass and decreasing fat mass) and muscle strength, and decreases the prevalence of cardiovascular risk factors, even without proven GH deficiency. […] The transition from paediatric to adult care is a vulnerable, yet important process. […] Due to the complexity of the syndrome, care for both children and adults with PWS should preferably be provided by an MD team. […] Regular patient care should include a systematic health watch, including screening for endocrine deficiencies and cardiovascular risk factors. […] We demonstrated that the combination of growth hormone treatment and multidisciplinary care has beneficial effects in patients with PWS.
  • #29 Prader-Willi syndrome – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/prader-willi-syndrome/diagnosis-treatment/drc-20356002
    Human growth hormone (HGH) treatment. HGH treatment helps infants and children with Prader-Willi syndrome grow. It also makes muscle tone better and lowers body fat. HGH also may be used in adults. A doctor who treats hormonal conditions, also known as an endocrinologist, can help find out whether your child would benefit from HGH and talk about any risks. […] Sex hormone treatment. Your endocrinologist may suggest that your child take hormone replacement therapy testosterone for males or estrogen and progesterone for females because of low levels of sex hormones. Hormone replacement therapy usually starts when your child reaches the usual age for puberty. It can lower the risk of bone thinning, also known as osteoporosis. Your child may need surgery to correct undescended testicles. […] Weight management. A dietitian can help you create a healthy, reduced-calorie diet to help manage your child’s weight while ensuring proper nutrition. A restricted-calorie diet may require supplemental vitamins or minerals to ensure balanced nutrition. Being more physically active and exercising can help manage weight and make your child better able to function physically.
  • #30 Prader-Willi Syndrome (PWS) Treatment: How Is PWS Treated?
    https://specialolympicsarizona.org/prader-willi-syndrome-treatment/
    As individuals with PWS enter puberty, sex hormone treatment may be considered. Sex hormone treatment aims to address these imbalances, supporting a more typical pubertal development and mitigating associated complications. […] Weight management is a critical aspect of caring for individuals with Prader-Willi syndrome. Implementing a carefully monitored and controlled diet is essential. The collaborative efforts of healthcare providers, nutritionists, and families play a crucial role in maintaining a healthy weight for individuals with PWS. […] Education therapy takes center stage in addressing the cognitive and developmental aspects of Prader-Willi syndrome. Tailored educational approaches are designed to meet the unique learning profiles of individuals with PWS. […] As with many disorders that affect physical and cognitive development, there are a number of therapies that emerge as options when looking for treatments for individuals with PWS.
  • #31 Prader-Willi Syndrome – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK553161/
    Adults, particularly those with persistent GHD, may also benefit from rhGH treatment. Close height monitoring is essential for all children and teenagers with Prader-Willi syndrome. While the disadvantage of rhGH is the need for daily or weekly injections, the treatment is associated with improved linear growth, reduced obesity, and enhanced bone density and motor function. Patients treated with rhGH during childhood are likelier to approach their predicted final adult height. […] Cryptorchidism is observed in most young boys with Prader-Willi syndrome. While human chorionic gonadotropin treatment may be effective in some cases, the majority require orchiopexy. Consultation with an endocrinologist is recommended at puberty since hormonal replacement may be indicated for delayed puberty. Treatment with testosterone is indicated for boys with delayed puberty, while girls receive estrogen replacement in the form of transdermal patches until the onset of menarche.
  • #32 Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China | Orphanet Journal of Rare Diseases | Full Text
    https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02302-z
    No consensus was reached on the age of starting rhGH treatment, although all agreed to the benefits of treating before the onset of obesity. […] Before initiation of rhGH therapy, patients with PWS should have a confirmed molecular diagnosis and expert multidisciplinary evaluation. […] It seems that GH treatment is generally safe and well tolerated. […] The early treatment of hypogonadism (within the first 6 months of life) is beneficial to many male patients with PWS. […] At present, the management of PWS is based on symptoms. […] Routine vaccination is recommended for patients with PWS when their conditions are stable and there are no other contraindications, such as severe malnutrition or infection.
  • #33 Prader-Willi Syndrome – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK553161/
    Hypothyroidism may also manifest, and routine testing is recommended to commence within the first year. Type 2 diabetes can emerge as a complication of severe obesity, and screening should be conducted if indicated. Sleep-disordered breathing, a common complication of obesity, affects most children and young adults. Individuals experiencing daytime sleepiness and behavior problems should be evaluated for obstructive sleep apnea (OSA), and in some cases, surgical intervention with tonsillectomy or adenotonsillectomy may be necessary.
  • #34 Prader-Willi Syndrome: Characteristics, Complications, and More
    https://www.healthline.com/health/prader-willi-syndrome
    diet and exercise supervision to avoid having obesity […] caregiver support and education […] language and speech therapy […] physical and occupational therapy […] mental health support […] treatment for any other related conditions, like: vision difficulties, hypothyroidism, central adrenal insufficiency, sleep issues, hip dysplasia, scoliosis. […] Without treatment, complications of PWS may include below average weight gain in infancy, short stature after puberty, and having obesity.
  • #35 Prader-Willi syndrome – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/prader-willi-syndrome/diagnosis-treatment/drc-20356002
    Human growth hormone (HGH) treatment. HGH treatment helps infants and children with Prader-Willi syndrome grow. It also makes muscle tone better and lowers body fat. HGH also may be used in adults. A doctor who treats hormonal conditions, also known as an endocrinologist, can help find out whether your child would benefit from HGH and talk about any risks. […] Sex hormone treatment. Your endocrinologist may suggest that your child take hormone replacement therapy testosterone for males or estrogen and progesterone for females because of low levels of sex hormones. Hormone replacement therapy usually starts when your child reaches the usual age for puberty. It can lower the risk of bone thinning, also known as osteoporosis. Your child may need surgery to correct undescended testicles. […] Weight management. A dietitian can help you create a healthy, reduced-calorie diet to help manage your child’s weight while ensuring proper nutrition. A restricted-calorie diet may require supplemental vitamins or minerals to ensure balanced nutrition. Being more physically active and exercising can help manage weight and make your child better able to function physically.
  • #36
    https://www.nhs.uk/conditions/prader-willi-syndrome/
    There’s no cure for Prader-Willi syndrome, so treatment aims to manage the symptoms and associated difficulties. […] This includes managing the person’s excessive appetite and behavioural challenges. […] One of the most important parts of caring for someone with Prader-Willi syndrome is to try to maintain a normal weight. […] They should have a healthy, balanced diet, avoiding sweet treats and high-calorie items right from the start. […] If someone with Prader-Willi syndrome is allowed to eat as much as they want, they’ll quickly become dangerously overweight. […] Limiting food intake can be very challenging. People with Prader-Willi syndrome may become frustrated when they want extra food, and their hunger can make them hide or steal food. […] The NCARDRS helps scientists look for better ways to prevent and treat Prader-Willi syndrome.
  • #37 Prader-Willi Syndrome – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK553161/
    Managing patients with Prader-Willi syndrome depends upon the affected individual’s age and involves evaluating and monitoring various organ systems. Infants with Prader-Willi syndrome exhibit muscular hypotonia, difficulty feeding, and inadequate weight gain, often necessitating a feeding team evaluation for specialized feeding techniques and the incorporation of high-calorie supplements or formulas. As hyperphagia emerges in childhood, restricting food intake is critical. Most patients have reduced energy needs, requiring approximately 70% of the calories compared to their age-matched peers without Prader-Willi syndrome. While an ideal calorie-restricted diet may lack sufficient vitamins and minerals, supplements should be prescribed to meet daily requirements, with caution against gummy vitamins due to their high caloric content and the risk of overdose, given their candy-like taste.
  • #38 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    Patients with Prader-Willi syndrome have hyperphagia and require restricted access to foods to minimize weight gain. […] Significant dietary restrictions are not implemented during early childhood to ensure optimal myelination. […] Institution of a balanced hypocaloric diet (1000 calories with supplementation of vitamins and calcium) is generally implemented at early school age with careful monitoring by a dietitian. […] In patients with morbid obesity, a protein-sparing, modified fast with careful medical and nutritional supervision over several weeks may facilitate short-term weight loss. […] Patients with Prader-Willi syndrome have hypotonia and require supplemental occupational and physical therapy to promote acquisition of gross and fine motor skills and to strengthen spinal musculature in order to minimize scoliosis. […] Encouragement of physical activity at home, at school (eg, increased physical education periods), and in the community (eg, Special Olympics) is essential for modulation of weight.
  • #39 What are the treatments for Prader-Willi syndrome (PWS)? | NICHD – Eunice Kennedy Shriver National Institute of Child Health and Human Development
    https://www.nichd.nih.gov/health/topics/prader-willi/conditioninfo/treatments
    Parents can enroll infants with PWS in early intervention programs. However, even if a PWS diagnosis is delayed, treatments are valuable at any age. […] The types of treatment depend on the individuals symptoms. The healthcare provider may recommend the following: […] Use of special nipples or tubes for feeding difficulties. […] Strict supervision of daily food intake. Once overeating starts between ages 2 and 4 years, supervision will help to minimize food hoarding and stealing and prevent rapid weight gain and severe obesity. […] Growth Hormone (GH) therapy. GH therapy has been demonstrated to increase height, lean body mass, and mobility; decrease fat mass; and improve movement and flexibility in individuals with PWS from infancy through adulthood. […] Treatment of eye problems by a pediatric ophthalmologist.
  • #40 Prader-Willi syndrome – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/prader-willi-syndrome/diagnosis-treatment/drc-20356002
    Early diagnosis and treatment can make quality of life better for people with Prader-Willi syndrome. A team of health professionals likely will manage the condition. […] Your child’s team may include a doctor who treats hormonal conditions, also known as an endocrinologist, as well as a behavior specialist, a dietitian, physical and occupational therapists, a speech and language therapist, a mental health professional, a geneticist, and other specialists. […] Although specific treatments vary depending on symptoms, most children with Prader-Willi syndrome will need: […] Good nutrition. Many infants with Prader-Willi syndrome have a hard time feeding because they have less muscle tone. Your child’s healthcare professional may recommend a high-calorie formula or special feeding methods to help your baby gain weight. They will monitor your child’s growth.
  • #41 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    In March 2025, the US Food and Drug Administration (FDA) approved diazoxide choline (Vykat XR) as the first drug for the treatment of hyperphagia in Prader-Willi syndrome. […] On June 20, 2000, the FDA approved the use of growth hormone in children with genetically confirmed Prader-Willi syndrome and evidence of growth failure. A study by Bakker et al indicated that growth hormone therapy improves the health-related quality of life (HRQOL) in children with Prader-Willi syndrome. […] A prospective cohort study by Donze et al reported that in infants and toddlers with Prader-Willi syndrome who underwent 3 years of growth hormone therapy, mental and motor development tended to see a greater increase in patients who began treatment at a younger age and who had lower psychomotor development at baseline.
  • #42 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-treatment
    A multinational study by Hughes et al indicated that persons with Prader-Willi syndrome can benefit from 24-hour professional support, including with regard to weight/body mass index reduction and improvement in behaviors of concern (ie, temper outbursts, skin picking, egocentrism, inflexibility, striving for dominance). […] Patients with Prader-Willi syndrome frequently require medical care for the following: initial management of hypotonia or poor feeding, evaluation for hypogonadism or hypopituitarism, management of sleep-related concerns – Central apnea, obstructive apnea, daytime somnolence, management of obesity, monitoring for scoliosis, therapy for behavioral issues. […] In March 2025, the US Food and Drug Administration (FDA) approved diazoxide choline (Vykat XR) as the first drug for the treatment of hyperphagia in Prader-Willi syndrome.
  • #43 The Evolving Landscape of Prader–Willi Syndrome Treatments
    https://www.delveinsight.com/blog/evolving-prader-willi-syndrome-treatments
    Current treatment options for PWS are limited, with management primarily focusing on lifestyle modifications to prevent obesity-related deaths. […] The PWS treatment is tailored to address the specific symptoms present in each individual. Growth hormone replacement therapy is the only FDA-approved PWS treatment for children. […] The FDA has approved three growth hormone products for PWS: GENOTROPIN, NORDITROPIN, and OMNITROPE. […] Since the FDA approved recombinant human growth hormone for Prader-Willi syndrome in 2000, several companies have struggled to develop more advanced treatments for hyperphagia, the insatiable hunger condition associated with PWS. […] However, on March 26, Soleno Therapeutics achieved a breakthrough with VYKAT XR (diazoxide choline), which became the first drug approved to treat hyperphagia.
  • #44 FDA Approves First Therapy for Hyperphagia in Prader Willi Syndrome | CheckRare
    https://checkrare.com/fda-approves-therapy-for-prader-willi-syndrome/
    The U.S. Food and Drug Administration (FDA) has approved Vykat XR (diazoxide choline), for the treatment of hyperphagia in patients four years of age and older with Prader-Willi syndrome (PWS). […] Diazoxide choline is a once-daily oral treatment that is capable of activating the adenosine triphosphate-sensitive potassium channel and crossing the blood-brain barrier. It is the first therapy to be approved for the treatment of hyperphagia in PWS. […] The approval follows positive data from the phase 3, multienter, randomized withdrawal, double-blind, placebo-controlled Study 2-RWP clinical trial. Results demonstrated a statistically significant worsening in hyperphagia for those randomized to switch to placebo compared to those who remained on diazoxide choline. Prior to this randomized withdrawal period, participants received double-blind and/or open-label diazoxide choline for a mean duration of 3.3 years. […] Additionally, the safety profile of the therapy is favorable with the most common adverse events being hypertrichosis, edema, hyperglycemia, and rash. These occurred in greater than or equal to 10% of participants.
  • #45 Potential Future Treatments – Prader-Willi Syndrome Association NZ
    https://www.pws.org.nz/medical-information/treatments-available/potential-future-treatments
    Following these findings, the Columbia research team began collaborating with Levo Therapeutics, a PWS-focused biotechnology company, to translate their research into therapeutics. […] Developing a drug to treat the complexities of hyperphagia in PWS has been a challenge for pharmaceutical companies, but there are several drugs in clinical trial stages. […] Exenatide and Liraglutide are both GLP Receptor Agonists, with the latter in phase 3 trial. […] DCCR (Diazoxide Choline Controlled Release) is thought to affect leptin pathways and improve GABA signalling. […] CSTI-500 is a triple monoamine reuptake inhibitor (similar to Tesomet), blocking the reuptake of serotonin, dopamine and norepinephrine. […] Oxytocin hormone treatment and Carbetocin, an oxytocin-like treatment, are also having positive effects on hyperphagia.
  • #46 Prader-Willi Syndrome Market Size to Reach USD 1,302.9 Million by 2035, Impelled by Increasing Awareness and Diagnosis Rates – BioSpace
    https://www.biospace.com/press-releases/prader-willi-syndrome-market-size-to-reach-usd-1-302-9-million-by-2035-impelled-by-increasing-awareness-and-diagnosis-rates
    Telehealth platforms and AI-powered apps are also turning into vital tools for remote patient monitoring and individualized treatment plans. […] Genotropin (Somatropin), is frequently used to treat growth failure in patients with Prader-Willi Syndrome (PWS). […] DCCR (Diazoxide Choline) developed by Soleno Therapeutics is an investigational treatment for Prader-Willi Syndrome (PWS) focused on tackling hyperphagia and metabolic problems. […] LV-101 (Intranasal Carbetocin) developed by Ferring Pharmaceuticals/Levo Therapeutics is a research oxytocin analog aimed at addressing hyperphagia and social-emotional challenges in Prader-Willi Syndrome (PWS). […] ARD-101 by Aardvark Therapeutics is an investigational oral therapy for Prader-Willi Syndrome (PWS) aimed at reducing hyperphagia and improving metabolic function.
  • #47 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    Patients with Prader-Willi syndrome have hyperphagia and require restricted access to foods to minimize weight gain. […] Significant dietary restrictions are not implemented during early childhood to ensure optimal myelination. […] Institution of a balanced hypocaloric diet (1000 calories with supplementation of vitamins and calcium) is generally implemented at early school age with careful monitoring by a dietitian. […] In patients with morbid obesity, a protein-sparing, modified fast with careful medical and nutritional supervision over several weeks may facilitate short-term weight loss. […] Patients with Prader-Willi syndrome have hypotonia and require supplemental occupational and physical therapy to promote acquisition of gross and fine motor skills and to strengthen spinal musculature in order to minimize scoliosis. […] Encouragement of physical activity at home, at school (eg, increased physical education periods), and in the community (eg, Special Olympics) is essential for modulation of weight.
  • #48 Guide | Physical Therapy Guide to Prader-Willi Syndrome | Choose PT
    https://www.choosept.com/guide/physical-therapy-guide-prader-willi-syndrome
    Physical therapists may provide treatment services in the home, at school, or in an outpatient clinic. The goal of physical therapy is to improve strength, endurance, coordination, and movement. […] Your physical therapist will perform an evaluation that includes: Parental concerns, Birth and developmental history, Medical history/health and behavioral concerns, Physical exam. […] Physical therapists educate parents about their infant’s condition. They teach activities parents can do with their child to promote movement and muscle strength. […] Exercise can help throughout your child’s life to protect against muscle loss, maintain bone strength, and manage weight. […] A physical therapist can continue to provide an exercise program and targeted training to help adults with PWS: Improve daily activity, Keep and improve overall mobility, Sustain quality of life, Get access to devices to assist with walking and moving later in life.
  • #49 Prader-Willi Syndrome – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK553161/
    Caregivers implement physical barriers, such as locking food cupboards and refrigerators and close supervision, to enforce food restrictions. Individuals with hyperphagia may neglect thoroughly chewing food, elevating the risk of choking and thus emphasizing the critical need for caregiver training in the Heimlich maneuver. In cases of severe obesity in older children and adults, treatment with weight loss medications and bariatric surgery can be considered. […] Hypotonia and motor delays in individuals with Prader-Willi syndrome can be effectively addressed through physical and occupational therapy. Additionally, early treatment with recombinant human growth hormone (rhGH) improves strength, physical function, and muscle development in pediatric patients with Prader-Willi syndrome. Formal growth hormone testing is not a prerequisite, and treatment with rhGH in children can be initiated upon diagnosis, preferably before the first birthday. Continuous treatment with rhGH during adolescence is recommended to maximize linear growth.
  • #50 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    Patients with Prader-Willi syndrome have hyperphagia and require restricted access to foods to minimize weight gain. […] Significant dietary restrictions are not implemented during early childhood to ensure optimal myelination. […] Institution of a balanced hypocaloric diet (1000 calories with supplementation of vitamins and calcium) is generally implemented at early school age with careful monitoring by a dietitian. […] In patients with morbid obesity, a protein-sparing, modified fast with careful medical and nutritional supervision over several weeks may facilitate short-term weight loss. […] Patients with Prader-Willi syndrome have hypotonia and require supplemental occupational and physical therapy to promote acquisition of gross and fine motor skills and to strengthen spinal musculature in order to minimize scoliosis. […] Encouragement of physical activity at home, at school (eg, increased physical education periods), and in the community (eg, Special Olympics) is essential for modulation of weight.
  • #51 Prader-Willi syndrome – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/prader-willi-syndrome/diagnosis-treatment/drc-20356002
    Treatment of sleep disturbances. Treating sleep apnea and other sleep problems can improve daytime sleepiness and behavioral issues. […] Various therapies. Your child likely will benefit from a range of therapies. These include physical therapy to make movement skills and strength better, speech therapy to make verbal skills better, and occupational therapy to learn everyday skills. Developmental therapy to learn age-appropriate behaviors, social skills and interpersonal skills also may help. In the U.S., early intervention programs with these types of therapy usually are available for infants and toddlers through a state’s health department. During school years, educational planning and support can improve learning. […] Behavior management. You may need to create schedules for your child and set strict limits on access to food and how much food is eaten. It’s important to be clear on what you expect in terms of your child’s behavior. Sometimes medicine is needed to manage behavioral problems.
  • #52 PWS Early Interventions: 5 Therapies for Prader-Willi Syndrome
    https://www.fpwr.org/blog/pws-early-interventions-5-therapies-for-prader-willi-syndrome
    early interventions should begin as soon as a diagnosis of PWS has been made. Research indicates early diagnosis and therapies may reduce the duration of tube feeding and prevent early obesity in Infants with PWS. Early intervention in children under age 3 years, particularly physical therapy, may improve muscle strength and encourage achievement of developmental milestones. […] The goal of early intervention and therapies is to help children meet these milestones earlier. Physical, occupational, and speech therapies are recommended for infants with PWS. […] Physical is helpful to improve balance, coordination, and strength. Your physical therapist will work with your child to improve gross motor skills such as lifting his head, sitting, crawling, and walking. […] Occupational therapy primarily assists with fine motor skill development and hand control. Occupational therapists will also perform activities to help with sensory integration and may perform oral motor exercises to improve sucking strength in preparation for pre-speech.
  • #53 Prader-Willi Syndrome: Therapy Options and Information | NAPAAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontResetNAPA 澳大利亚普通话信息
    https://napacentre.com.au/prader-willi-syndrome/
    Early intervention should begin as soon as a diagnosis of PWS has been made as it can result in significant improvements in gross motor, fine motor, communication and oral-motor skills. Physiotherapy may focus on improving mobility, muscular strength, coordination, and endurance. Occupational therapy may target improving upper limb strength, upper extremity function, and posture to support activities of daily living, such as dressing. Speech and language pathology may support with increasing speech intelligibility (i.e., ability to be understood), developing expressive (i.e., using) and receptive (i.e., understanding) language and developing oral motor skills related to feeding in the early years such as sucking. Lastly, a dietician may be a part of your child’s multidisciplinary team to support nasal-gastric tube weaning and developing a feeding plan.
  • #54 PWS Early Interventions: 5 Therapies for Prader-Willi Syndrome
    https://www.fpwr.org/blog/pws-early-interventions-5-therapies-for-prader-willi-syndrome
    Early assessment and intervention are critical to the development of functional communication. Parents are strongly encouraged to begin oral-motor therapy in infancy to assist with feeding and the acquisition of the oral-motor skills necessary for babbling and speech. […] Hippotherapy is commonly recommended for children ages 2 and above. The horses rhythmic, repetitive movements work to improve muscle tone, balance, posture, coordination, strength, flexibility, and cognitive skills. […] Research shows infant massage is beneficial in improving blood circulation, aiding digestion, enhancing the development of the nervous system, stimulating neurological development, increasing alertness, and improving immune function.
  • #55 Prader-Willi Syndrome (PWS) Treatment: How Is PWS Treated?
    https://specialolympicsarizona.org/prader-willi-syndrome-treatment/
    Cognitive behavioral therapy (CBT) is a valuable therapeutic approach for managing behavioral challenges associated with Prader-Willi syndrome. […] Physical therapy plays a crucial role in addressing the musculoskeletal challenges often present in individuals with Prader-Willi syndrome. […] Speech-language therapy is essential for individuals with Prader-Willi syndrome who may encounter challenges in speech and language development. […] Living with Prader-Willi syndrome involves a holistic approach that extends beyond specific treatments. Other treatments that many individuals turn to when it comes to living with PWS include: […] Ongoing nutritional counseling provides guidance on maintaining a balanced diet, managing food-related behaviors, and preventing excessive weight gain.
  • #56 Prader-Willi Syndrome: Causes, Symptoms, Treatment
    https://www.gillettechildrens.org/conditions-care/prader-willi-syndrome
    To help manage these behavioral issues, daily routines, firm rules and positive rewards can help. […] Because many children who have Prader-Willi syndrome experience motor delays, physical therapy, and occupational therapy can help develop, strengthen, and refine physical abilities. […] If your child experiences delays in speech, speech-language therapy might help.
  • #57 Jump Start Program For Children With Prader-Willi SyndromeAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontReset
    https://nexushealthsystems.com/programs/jump-start-program-for-prader-willi-syndrome/
    Increase physical mobility. […] Resolve weight-related conditions. […] Develop strategies to manage behavior. […] Improve overall quality of life. […] During their stay, patients adjust to personalized calorie-controlled diets, learn how to set schedules, and develop physiological and emotional strength through physical, occupational, speech, recreational, music, and pet-based therapies. […] Jump Start is the only nationally recognized inpatient program offering comprehensive care for people with weight-related conditions such as PWS. […] Jump Start Program services: Cognitive Therapy, Occupational Therapy, Physical Therapy, Psychiatry & Behavioral Management, Recreational Therapy, Respiratory Therapy/Pulmonary, Speech Therapy.
  • #58 Prader-Willi Syndrome – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK553161/
    Most patients with Prader-Willi syndrome experience behavior or psychiatric diagnoses, with about a quarter of children meeting the diagnostic criteria for autism spectrum disorder. Adolescents and adults with mood disorders or psychoses may require medication and therapy. […] Behavioral strategies assist patients in understanding rules, schedules, expectations, and verbal cues, minimizing symptoms of compulsion and aggression. Skin picking is frequent, and a study demonstrated the benefits of treatment with oral guanfacine. […] Reduced bone mineral density is typical, and patients should undergo evaluation through DXA scans every 2 to 3 years, starting from the age of 5 years. Scoliosis is also common, and it is advisable to monitor pediatric patients during routine visits, referring them for orthopedic evaluation when indicated.
  • #59 What are the treatments for Prader-Willi syndrome (PWS)? | NICHD – Eunice Kennedy Shriver National Institute of Child Health and Human Development
    https://www.nichd.nih.gov/health/topics/prader-willi/conditioninfo/treatments
    Treatment of curvature of the spine by an orthopedist. […] Sleep studies and treatment. Sleep disorders are common with PWS. Treating a sleep disorder can help improve the quality of sleep. […] Physical therapy. Muscle weakness is a serious problem among individuals with PWS. […] Behavioral therapy. People with PWS have difficulty controlling their emotions. Using behavioral therapy can help. […] Medications. Medications, especially serotonin reuptake inhibitors (SRIs), may reduce obsessive-compulsive symptoms. […] Early interventions/Special needs programs. Individuals with PWS have varying degrees of intellectual difficulty and learning disabilities. […] Sex hormone treatments and/or corrective surgery. […] Replacement of sex hormones. Replacement of sex hormones during puberty may result in development of adequate secondary sex characteristics. […] Placement in group homes during adulthood. Group homes offer necessary structure and supervision for adults with PWS, helping them avoid compulsive eating, severe obesity, and other health problems.
  • #60 What Is Prader-Willi Syndrome? Symptoms, Causes, Diagnosis, Treatment, and Prevention
    https://www.everydayhealth.com/prader-willi-syndrome/guide/
    Human growth hormone is approved to treat Prader-Willi syndrome. […] Children can start on growth hormone treatment as early as age two to three months. […] Antidepressants called selective serotonin reuptake inhibitors (SSRIs) may be helpful for the behavioral and emotional symptoms of Prader-Willi syndrome. […] Children with Prader-Willi syndrome will need a variety of therapies to improve their motor and intellectual skills and manage behavioral issues. […] Cognitive behavioral therapy (CBT) helps to identify and change harmful behaviors. […] Carefully monitoring and restricting food access can help prevent rapid and extreme weight gain. […] Surgery is typically done to fix undescended testicles, because without treatment, this problem can increase the risk for testicular cancer. […] Bariatric surgery isn’t recommended for people with Prader-Willi syndrome. […] Children with Prader-Willi syndrome need to eat a carefully controlled diet, with small portions and an emphasis on fruits and vegetables instead of carbs. […] Exercise is an important complement to diet.
  • #61 Prader-Willi Syndrome (Causes, Symptoms and Treatment)
    https://patient.info/doctor/prader-willi-syndrome-pro
    Many drugs have been used to modify behaviour but they tend to be ineffective or even counterproductive. Olanzapine may have an effect. Haloperidol and fluoxetine are sometimes effective. Selective serotonin reuptake inhibitors (SSRIs) seem to have a nonspecific behaviour-stabilising effect, with fewer outbursts, a marked reduction in irritability and less perseveration but with no antidepressant effect. […] All these drugs may be tried with care. None is universally successful and they may even be counterproductive.
  • #62 Other Medicines – Prader-Willi Syndrome Association NZ
    https://www.pws.org.nz/medical-information/treatments-available/other-medicines
    Below is a list of medicines that doctors may sometimes prescribe to treat specific symptoms of PWS (available in NZ as stated, June 2019). […] In PWS, fluoxetine is often prescribed for reducing anxiety, stabilising behaviour or for depression. […] Amitriptyline is not commonly prescribed in PWS, but is sometimes used as an off-label treatment for sleep problems when taken in the evening. […] Clonidine is another medicine sometimes used in PWS for its off-label benefits. […] For some children with PWS, Melatonin may improve sleep quality and help with early waking. […] In PWS stimulants can improve impulsivity, daytime sleepiness, focus and attention, but the effects differ for individuals and are dose dependent. […] It has been suggested that Lithium might be one of the most effective long term treatments for mood stabilising in terms of patients being less likely to have a recurrence.
  • #63 Prader-Willi Syndrome – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK553161/
    Hypothyroidism may also manifest, and routine testing is recommended to commence within the first year. Type 2 diabetes can emerge as a complication of severe obesity, and screening should be conducted if indicated. Sleep-disordered breathing, a common complication of obesity, affects most children and young adults. Individuals experiencing daytime sleepiness and behavior problems should be evaluated for obstructive sleep apnea (OSA), and in some cases, surgical intervention with tonsillectomy or adenotonsillectomy may be necessary.
  • #64 Prader-Willi Syndrome – Child Neurology Foundation
    https://www.childneurologyfoundation.org/disorder/prader-willi-syndrome/
    Support may involve: Parent groups, A social worker, A psychotherapist. […] An IEP is set up with a school. It gives a child the best possible education. […] Treatments may be needed for: Scoliosis, Other abnormalities affecting specific organs. […] Patients with abnormal eye findings may require corrective glasses or surgery. […] If their sleep is abnormal, a patient may require surgery. Surgeries can include removal of the tonsils or adenoids (glands at the back of the nasal cavity). They may also need a breathing machine called a continuous positive airway pressure (CPAP) machine.
  • #65 Prader-Willi Syndrome – Scoliosis and Spine Associates
    https://www.scoliosisassociates.com/conditions/prader-willi-syndrome/
    Because of decreased muscle tone and increased body weight, sleep apnea is common among children with Prader-Willi syndrome. This can be managed with a positive airway pressure machine (i.e., CPAP). […] Because of the unique nature of the condition, patients with Prader-Willi syndrome should be followed by and cared for by an orthopedic surgeon, particularly someone with experience in scoliosis care. […] Treatment of scoliosis can involve casting, bracing, physical therapy, and surgery. Scoliosis that is diagnosed in an infant (up to age 3) with Prader-Willi syndrome may be successfully treated by casting the spine. Bracing, specifically a thoracic-lumbar-sacral orthosis or TLSO, is used to treat scoliosis in children older than three years of age. The TLSO is worn for 16-20 hours per day to be effective. The time in brace is reduced over time as the patient achieves skeletal (bone) maturity or the end of growth.
  • #66 Prader-Willi Syndrome – Scoliosis and Spine Associates
    https://www.scoliosisassociates.com/conditions/prader-willi-syndrome/
    If the curvature of the spine exceeds about 40 to 50°, scoliosis surgery is required. Spinal fusion is a curative option for scoliosis, but in younger children (up to 10 years of age), the surgery could permanently restrict growth of the spine and chest. Alternatively, orthopedic surgeons can use expandable implants to correct spine curvature and permit bone growth. If these options fail, however, definitive spinal fusion surgery may be needed. Indeed, definitive spinal fusion is the treatment of choice in older children with Prader-Willi syndrome and scoliosis. Newer tethering procedures in which growth and motion are preserved can be offered to select patients.
  • #67 Prader-Willi Syndrome – Child Neurology Foundation
    https://www.childneurologyfoundation.org/disorder/prader-willi-syndrome/
    Prader-Willi syndrome (PWS) is a genetic disorder. It affects multiple organs. PWS is the most common genetic cause of childhood obesity. […] There is no cure for PWS. However, supportive care is available. […] Currently, there is no cure for PWS. However, supportive care is available. […] Many children will need special nipples for bottles. They may also need a feeding tube in infancy and early childhood. Children may need to work with a dietician for obesity later in life. […] Supplements can increase low levels of calcium and vitamin D. Both are important for bone health. […] Endocrine problems may occur. Certain hormones can correct these. Hormones may include: Testosterone, Human chorionic gonadotropin, Growth hormone. […] Therapies may involve: Speech therapy, Physical therapy, Occupational therapy.
  • #68 Clinical Trials – Prader-Willi Syndrome Association | USA
    https://www.pwsausa.org/what-we-do/clinical-trials/
    Clinical trials help scientists develop medications to treat Prader Willi Syndrome. […] When your child participates in a clinical trial, they are contributing to the advancement of treatment options for individuals living with PWS. […] In Phase 2, the treatment is tested on a larger group with the specific condition, like Prader-Willi Syndrome. The focus is on evaluating its effectiveness and monitoring for side effects or adverse reactions. […] In this phase, the treatment is compared to current standards or placebos. The goal is to further evaluate its effectiveness, safety, and benefits against other options. […] In Phase 4, the treatment is implemented in clinical practice. Long-term studies assess its real-world effectiveness and longevity beyond trials. […] Phase 5 involves the implementation and dissemination of the treatment in clinical practice. Long-term follow-up studies track patients progress and outcomes over an extended period to assess the treatments real-world effectiveness, durability, and benefits beyond the clinical trial setting. […] Safety is a top priority in clinical trials. Rigorous measures are in place to ensure participant well-being and minimize risks. […] The aim of clinical trials is to advance medical knowledge while maintaining the utmost safety for participants.
  • #69 Potential Future Treatments – Prader-Willi Syndrome Association NZ
    https://www.pws.org.nz/medical-information/treatments-available/potential-future-treatments
    An alternative to using drugs as therapeutics is the use of devices to stimulate brain activity in specific regions. […] Preliminary data in 5 adults with PWS showed some reduction in hyperphagia symptoms so Dr Merlin Butler and his team at Kansas University conducted a further study involving 10 adults with PWS, plus obese and healthy weight controls. […] Parent of a child with PWS, immunologist and co-founder of The Chion Foundation, Lara C. Pullen, PhD, identified pitolisant as an ideal drug to be repurposed to treat many clinical manifestations of PWS. […] In 2021, a double-blind, placebo controlled phase 2 study was launched to evaluate pitolisant for excessive daytime sleepiness, cognition, and behavioural function in PWS, enrolling patients 6 65 years at various sites across the USA.
  • #70 Neuromodulation for the treatment of Prader-Willi syndrome – A systematic review » Department of Neurology » College of Medicine » University of Florida
    https://neurology.ufl.edu/2024/03/22/neuromodulation-for-the-treatment-of-prader-willi-syndrome-a-systematic-review/
    Prader-Willi syndrome (PWS) is a complex, genetic disorder characterized by multisystem involvement, including hyperphagia, maladaptive behaviors and endocrinological derangements. […] Various non-invasive and invasive device-based neuromodulation methods, including vagus nerve stimulation (VNS), transcranial direct current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), and deep brain stimulation (DBS) have all been reported to be potentially promising treatments for addressing the major symptoms of PWS. […] Through our comprehensive search, there were a total of 47 patients who had undergone device-based neuromodulation therapy for PWS. Two articles described VNS, 4 tDCS, 1 rTMS and 2 DBS, targeting different symptoms of PWS, including aberrant behavior, hyperphagia and weight.
  • #71 Potential Future Treatments – Prader-Willi Syndrome Association NZ
    https://www.pws.org.nz/medical-information/treatments-available/potential-future-treatments
    PWS research is examining many aspects of the syndrome, looking to further understand symptom causes, develop new management strategies and find potential treatments. […] Gene therapy alters DNA and remains an experimental technique in the world of medical research with very few treatments approved for medical use worldwide, but it is hoped that gene therapy techniques will be used in the future to treat disorders without the need for drugs or surgery. […] Activating these genes has the potential to restore normal cell function and might improve clinical characteristics. […] Dr. Yong-hui Jiang has screened thousands of drug compounds searching for small molecules that could activate PWS gene expression in cells derived from PWS mice and has found two compounds that seem to have this ability UNC0638 and UNC0642.
  • #72 Potential Drug Appears to Ease Effects of Prader-Willi Syndrome | Duke Health
    https://corporate.dukehealth.org/news/potential-drug-appears-ease-effects-prader-willi-syndrome
    DURHAM, N.C. Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome. […] If the findings by the Duke-led team bear out in human studies, the drug could become the first treatment option for Prader-Willi syndrome. […] Our findings are promising and indicate that we may have a path forward for the first time to treat the severe, life-limiting features of this genetic disorder, said Yong-hui Jiang, M.D., Ph.D., associate professor in Dukes departments of Pediatrics and Neurobiology. […] A class of small molecule that are known as G9a inhibitors were successful, both in the mouse model of Prader-Willi syndrome and in human cells from patients with the disorder. […] The G9a inhibitors also appeared to have a therapeutic effect. When mice with Prader-Willi syndrome were treated with these small molecule drugs during infancy, they lived longer and had more normal growth.
  • #73 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-treatment
    A double-blind, placebo-controlled, crossover study by Miller et al suggested that low-dose intranasal oxytocin therapy may reduce appetite drive in patients with Prader-Willi syndrome, as well as improve socialization, anxiety, and repetitive behaviors in these individuals. […] Patients with Prader-Willi syndrome may require operative care for treatment of complications of obesity, treatment of cryptorchidism, and treatment of sleep apnea, as well as for scoliosis intervention. […] Patients with Prader-Willi syndrome have hyperphagia and require restricted access to foods to minimize weight gain. […] In patients with morbid obesity, a protein-sparing, modified fast with careful medical and nutritional supervision over several weeks may facilitate short-term weight loss. […] Encouragement of physical activity at home, at school (eg, increased physical education periods), and in the community (eg, Special Olympics) is essential for modulation of weight.
  • #74 Prader-Willi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care
    https://emedicine.medscape.com/article/947954-followup
    In addition, the group recommends that in patients under age 5 years on growth hormone therapy, a level 2 sleep study be performed at least every 2-3 years, with such studies run sooner if there is a clinical suggestion of worsening obstructive sleep apnea. […] According to the consensus group, in adults with Prader-Willi syndrome, growth hormone therapy can be used up to age 25 years, but that after that, the data supporting this intervention are sparse. […] A double-blind, placebo-controlled, crossover study by Miller et al suggested that low-dose intranasal oxytocin therapy may reduce appetite drive in patients with Prader-Willi syndrome, as well as improve socialization, anxiety, and repetitive behaviors in these individuals. […] Patients with Prader-Willi syndrome may require operative care for treatment of complications of obesity, treatment of cryptorchidism, and treatment of sleep apnea, as well as for scoliosis intervention.
  • #75 Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies | Translational Psychiatry
    https://www.nature.com/articles/s41398-022-02054-1
    The prosocial neuropeptide oxytocin is being developed as a potential treatment for various neuropsychiatric disorders including autism spectrum disorder (ASD). […] Given the frequently observed autism-like behavioral phenotypes in Prader-Willi and Schaaf-Yang syndromes, it is unclear whether oxytocin treatment represents a viable option to treat behavioral symptoms in these diseases. […] Here we review the latest findings on intranasal OT treatment, Prader-Willi and Schaaf-Yang syndromes, and propose novel research strategies for tailored oxytocin-based therapies for affected individuals. […] One study assessed the efficacy of intranasal OT in children with PWS and reported trends for improvement in several behavioral parameters, including irritability, lethargy, stereotype, and hyperactivity, as well as a significant improvement of overall SRS score on day 6 after the treatment.
  • #76 Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies | Translational Psychiatry
    https://www.nature.com/articles/s41398-022-02054-1
    Another study found no effects of OT on social behavior and hyperphagia in the total group, but the authors reported improvements for anger, sadness, conflicts, social- and food-related behavior in children under 11 years, thus highlighting the importance of proper subgroup analysis. […] Finally, Tauber and colleagues reported that OT might help increasing trust in others and decreasing disruptive behaviors in PWS patients, as well as significant improvements of social skills and feeding in infants with PWS. […] While most of these results are very encouraging, the central question remains: What variables determine if, when, and how OT improves PWS-related symptoms? […] In a comprehensive review, Rice and colleagues conclude that given the lack of convincing evidence, currently no conclusive statement about the efficacy of intranasal OT as a treatment for PWS can be made.
  • #77 Early oxytocin treatment in infants with Prader–Willi syndrome is safe and is associated with better endocrine, metabolic and behavioral outcomes | Orphanet Journal of Rare Diseases | Full Text
    https://ojrd.biomedcentral.com/articles/10.1186/s13023-025-03560-3
    Early OT treatment in infants with PWS is safe up to 34 years of age. OT-exposed children display better social, endocrine and metabolic outcomes. This study documents for the first time in human the biological window of opportunity of early OT treatment, which may change the trajectory of the PWS condition. […] We found a strong signal regarding the socialization domain, with a trend toward higher scores and more children with adequate socialization scores in the OT-exposed group compared to the non-exposed group. […] The current study showed differences between the OT-exposed group and the non-exposed group in the brain connectivity of regions involved in neurodevelopment which were identified in the OTBB2 study. […] This study documents for the first time in human the critical postnatal period that offers a window of opportunity to implement OT treatment to change the trajectories of the disease.
  • #78 Jump Start Program For Children With Prader-Willi SyndromeAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontReset
    https://nexushealthsystems.com/programs/jump-start-program-for-prader-willi-syndrome/
    Young people with established weight control problems, including Prader-Willi Syndrome (PWS), face significant obstacles that impact every aspect of life. […] In the Jump Start Program, we offer a structured, inpatient environment in which children receive the medical care, support, and guidance they need to reach weight loss and overall health goals. […] Program features: Individualized treatment plans that address medical issues and behavioral complications. […] Physical, occupational, and speech therapy. […] Recreational, music, art, and pet therapy. […] Emotional and social support for individuals and families. […] Offering a welcoming, home-like setting, the Jump Start Program helps patients decrease BMI while addressing co-occurring medical conditions. […] Program goals: Decrease body mass index (BMI).
  • #79 Treating Prader-Willi Syndrome – Jump Start ProgramAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontReset
    https://nexushealthsystems.com/what-is-prader-willi-syndrome-how-can-nexus-changes-health-wellness-program-help/
    Prader-Willi Syndrome (PWS) is a rare genetic disorder that affects learning and behavior resulting from an abnormality on the 15th chromosome. Addressing comorbid medical issues and behavioral complications characteristic of individuals with PWS, the inpatient program helps young patients who have found traditional outpatient programs unsuccessful. Specific goals are set for every child regarding the following: Decreasing BMI, Resolving weight-related conditions, Developing strategies to manage behavior, Developing strategies to decrease unstructured time, Developing coping skills for home, school, and in the community, Improving overall quality of life. The Jump Start Program incorporates low-calorie diets, set daily schedules, and individualized physical training regimens. Behavioral health support is also available for both the patient and family members. The inpatient program admits youth from three to twenty-one years of age from across the country since there is really nothing else available.
  • #80 Jump Start Program For Children With Prader-Willi SyndromeAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontReset
    https://nexushealthsystems.com/programs/jump-start-program-for-prader-willi-syndrome/
    Increase physical mobility. […] Resolve weight-related conditions. […] Develop strategies to manage behavior. […] Improve overall quality of life. […] During their stay, patients adjust to personalized calorie-controlled diets, learn how to set schedules, and develop physiological and emotional strength through physical, occupational, speech, recreational, music, and pet-based therapies. […] Jump Start is the only nationally recognized inpatient program offering comprehensive care for people with weight-related conditions such as PWS. […] Jump Start Program services: Cognitive Therapy, Occupational Therapy, Physical Therapy, Psychiatry & Behavioral Management, Recreational Therapy, Respiratory Therapy/Pulmonary, Speech Therapy.
  • #81 Prader Willi Syndrome Clinic
    https://www.nationwidechildrens.org/specialties/prader-willi-syndrome-clinic
    Prader-Willi Syndrome (PWS) is treated at Nationwide Childrens Hospital by a team of dedicated pediatric experts. […] We focus on early intervention for every child. From newborns to young adults, our team works with you to create an individualized approach to diagnose and treat possible complications that can be associated with PWS. […] The expert pediatric care team includes an endocrine nurse coordinator, endocrinologists, a geneticist, a genetic counselor, neurologist, psychologist, dietitian and social worker who attend each PWS Clinic. […] Assists families with all aspects of growth hormone therapy. […] Determines age appropriate and individual treatment plans for your child. […] Directs growth hormone therapy and other endocrine replacement hormones. […] Discusses specialized care needs with families and the PWS team.
  • #82 Prader Willi Syndrome Clinic
    https://www.nationwidechildrens.org/specialties/prader-willi-syndrome-clinic
    Determines need for additional therapies and supportive services. […] Assists with behavioral/emotional difficulties seen in patients with PWS. […] Provides nutrition counseling and recommendations. […] Assists in developing a nutrition care plan to meet each familys needs. […] Provides ongoing support with coping/adjustment to PWS throughout life stages.
  • #83 UNC Multidisciplinary Prader-Willi Syndrome Clinic | Department of Pediatrics
    https://www.med.unc.edu/pediatrics/gene/clinical/unc-multidisciplinary-prader-willi-syndrome-clinic/
    Medical and nutrition management can help prevent or treat some secondary complications of this disorder. […] Appointments are tailored to address each familys individual needs for education about Prader-Willi syndrome, medical and psychoeducational evaluation, and therapeutic management and referral options for this complex condition.
  • #84 Prader-Willi syndrome – Overview of Information and Clinical Research
    https://clinicaltrials.eu/disease/prader-willi-syndrome/
    Individuals with PWS often experience hypotonia (reduced muscle tone) and require physical and occupational therapy to improve motor skills and strengthen muscles. Encouraging physical activity at home, school, and in the community is vital for weight management and overall health. […] Other treatments for PWS include addressing sleep disturbances, such as sleep apnea, and managing complications like scoliosis and dental issues. In some cases, surgical interventions may be necessary for conditions like cryptorchidism and severe obesity. Experimental therapies, such as low-dose intranasal oxytocin, show promise in reducing appetite and improving socialization and anxiety. […] The management of Prader-Willi Syndrome (PWS) is multifaceted, involving a combination of medical, nutritional, and psychological interventions. Early diagnosis is critical, as it allows for timely implementation of therapies that can significantly improve outcomes. Growth hormone therapy is a cornerstone treatment, enhancing physical development and quality of life. Hormonal treatments address deficiencies in sex hormones, while weight management strategies are essential to combat the insatiable appetite and low metabolic rate characteristic of PWS. Behavioral and mental health support is necessary to address the psychological challenges associated with the syndrome. Physical and occupational therapies are vital for improving motor skills and muscle tone. Additionally, addressing complications such as sleep disturbances and scoliosis is important for overall health. Ongoing research and clinical trials continue to explore new treatment avenues, offering hope for better management and potential future cures. With comprehensive care, individuals with PWS can achieve improved life expectancy and quality of life.